Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Braintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapies

The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, today announces that its Braintree Manufacturing Innovation Centre (Braintree MIC) has successfully received a Medicines and Healthcare products Regulatory Agency (MHRA) Manufacturers and Importers Authorisation for Investigational Medicinal Products (MIA(IMP)) and associated Good Manufacturing Practice (GMP) certificate.

Published on the 5th of March 2024. Read the full news here.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (5 novembre 2024). Braintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapies. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/12mia


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.